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Abstract: 
Objective: To determine the peripheral neuropathy among sufferers of liver cirrhosis 
Methodology:- This was a observational cross sectional study, conducted at Ward 7 (MU-III),  Jinnah 
Postgraduate Medical Center (JPMC), Karachi for Six months from 10th February 2016 to 9th August 2016.  
Total 195 patients of liver cirrhosis of more than 5 years duration with Child Pugh (A,B,C) were encompassed 
in the study using the purposive sampling technique. Nerve conductivity testing with surface electrodes was 
carried out in all four limbs including motor and sensory fibers of ulnar, median, tibial, and peroneal nerves as 
well as in sensory fibers of sural nerve. PN was diagnosed if more than one peripheral nerve was affected on 
nerve conduction study. 
Results: There were 119 male and 76 female patients with mean age of  45.19±8.41 yrs. The mean duration of 
disease was 8.85±1.69 years, with range 5(6–11) years. The child pugh class of 29.2% were class-A, 26.7% 
were class-B, and 44.1% were class-C. The peripheral neuropathy was observed in 59% patients. No any 
statistically significant association was observed with gender, age, child pugh class, and duration of disease. 
Conclusion:  This study concluded that peripheral neuropathy is a possible complication of liver cirrhosis 
irrespective of etiology. The neuropathy was more prevalent in male gender, age >45 years and duration of 
disease 9-11 years. 
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INTRODUCTION: 
Cirrhosis of liver shares a huge burden of 
morbidity and mortality throughout the globe [1]. 
Routine clinical or laboratory examination reveals 
cirrhosis in as many as 40% of sufferers who 
remain silent without a single symptom. In our 
hospital, the patients of cirrhosis presented usually 
with serious and life-threatening complications 
like encephalopathy, ascites, and gastrointestinal 
bleed [1-3]. Most studies focused on portal 
hypertension, variceal bleeding, overt hepatic 
encephalopathy, while complication like 
peripheral neuropathy (PN) were seldom studied. 
Dayan and Williams were the founders of 
relationship of PN and cirrhosis [4]. Peripheral 
neuropathy need to be focused as it is important 
complication of cirrhosis of liver that may 
seriously impair patient's routine daily activities 
and quality of life [5,6]. 
It is stated that peripheral neuropathy has a 
momentous association with both liver cirrhosis 
and chronic hepatitis and is more marked with 
advanced liver disease [7].  However, only few 
hepatologist really screen patients for Peripheral 
neuropathy due to time-consuming 
neurophysiological tests [8]  and controversies in 
literature about the presence of peripheral 
neuropathy in liver cirrhosis [9]. Chari VR et. al. 
discovered PN in 63.3% and 16.6% in cirrhotic 
and chronic hepatitis respectively. Further 
elaboration revealed 33.3% with abnormal 
conduction velocities and 80% with 
demyelination in patients with hepatic cirrhosis 
and in cases with chronic hepatitis, 41.6% were 
with abnormal conduction velocity and 75% with 
segmental demyelination [10].  Jain et al found 
peripheral neuropathy in 111 out of 207 (53.6%) 
of the study subjects with cirrhosis of liver [11].  
Santoro et al. found the prevalence of peripheral 
neuropathy to be 15.3% [12]. Kharbanda et al 
found it to be 73% [13]. 
As various studies revealed variable prevalence of 
peripheral neuropathy varying from 19-80% in 
the cirrhotic patients on nerve conduction studies. 
Current study would help to establish the local 
perspective as there is paucity of local data. 
Thereby regular screening of suspected patients 
would help identify the problem so that timely 
intervention can be done to prevent adverse 
outcome as already cirrhosis of liver poses a huge 
financial and psychological burden for the 
patients and their families. Since treatment 
regimens are limited early diagnosis of is the most 
effective approach especially in resource 
restrained settings [14].  
MATERIAL AND METHODS: 
This was an observational cross-sectional study 
conducted at ward 07(MUIII), Jinnah Hospital, 
Karachi from 10th February 2016 to 9th August 
2016. Total 195 patients via Descriptive purposive 
sampling technique based on the formula of fixed 
proportions keeping in view of 53.6% prevalence 
of peripheral neuropathy in liver cirrhosis 
calculated through WHO Software was selected 
with a 95% CI (confidence interval) and 7% error 
margin. Consented patients with cirrhosis had 
included from outdoor facilities on the basis of 
inclusion and exclusion criteria. Diagnosed patient 
of liver cirrhosis of more than 5 years duration with 
Child Pugh (A,B,C) of either gender but age 
between 30-60 years were included. Non-
consenting, Known hypertensive, patients with 
history of diabetes mellitus or alcohol consumption 
or Vitamin B 12 deficiency having level < 150 
mg/L, Gullian-Barre Syndrome, leprosy, vesicular 
dermatosis, allergic contact dermatitis were in 
exclusion. After brief history regarding 
sociodemographic data and diseases duration, a 
trained technician performed the nerve conduction 
veocity in both arms (Median, Ulnar and Radial 
nerve’s both efferent and afferent fibers) and legs 
(Sural nerve’s afferent fibers). PN was diagnosed 
in patients with >1 peripheral nerve involvement. 
Structured proformas were utilized to maintain and 
assemble the recordings and data. Data analysis 
was achieved by SPSS 16.  
 
 RESULTS: 
195 cases were included in the study from which 
119(61.02%) were male and 76 (38.9%) female. 
The mean age 45.19±8.41 years, range 30(30–60) 
years which was stratified in two groups. Age of 
102 (52.3%) patients was ≤45 years and age of 
93(47.7%) patients was >45 years. The mean 
duration of disease was 8.85±1.69 years, with 
range 5(6–11) years which was stratified in two 
groups. The duration of 72 (36.9%) patients was 5-
8 years and 123 (63.07%) patients were 9-11 years. 
Majority 86(44.1%) were in child pugh C while 57 
(29.2%) and 52(26.7%) were in A and B 
respectively. 124(63.6%) patients were smokers 
i.e. they had history of more than 1 pack year of 
smoking.  
Peripheral neuropathy was observed in 115(59.0%) 
patients from which 73 (63.4%) were male patients 
and 42 (36.5%) were female. “Figure 1” The 
descriptive statistics of age and duration of disease 
according to peripheral neuropathy were 
calculated. It was observed that mean age of 
patients with peripheral neuropathy was 
45.27±7.88 years while mean duration of disease 
was 8.75±1.69 years. “TABLE 1” 
Stratification with respect to smoker, duration of 
disease and child pugh class was done to observe 
association of these modifiers with peripheral 
neuropathy. Post stratification, chi square test 
results revealed that no significant association 
(p>0.05) with smoking ( 0.064), duration of disease 
(p=0.643) and child pugh class (0.863). “TABLE 
2”. 
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Fig 1: Frequency or Percentage of Cirrhotic Patients According To Peripheral Neuropathy (n=195)  
  
 
                Table 1: Descriptive Statistics of Gender, Age (years) and Duration of Disease according To 
Peripheral Neuropathy (n=195) 
  
  
PERIPHERAL NEUROPATHY 
PRESENT 
(n=115)  
ABSENT 
(n=80)   
AGE 
(Mean ±SD)  
45.27±7.88  45.09±18  
DURATION OF 
DISEASE 
(Mean ±SD)  
8.75±1.69  8.99±1.70  
 
Table 2: Frequency and Association of Smoker, Duration of Disease and Child Class According to 
Peripheral Neuropathy (n=195) 
  
  
PERIPHERAL NEUROPATHY 
TOTAL P VALUE PRESENT 
(n=115)  
ABSENT 
(n=80)   
SMOKER 
YES  67 57  124 
0.064 
NO  48  23  71 
DURATION OF DISEASE 
5-8 years 44 28 72 
0.064 
9-11 years 71 52 123 
CHILD CLASS 
 Clas-A 34  23  57  
0.863 Class-B 32  20  52  
Class-C 49  37  86  
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DISCUSSION: 
The involvement of nervous system central, 
peripheral or autonomic is common in liver 
cirrhosis [15].  Many studies support the fact that 
PN is the complication of liver diseases but 
mechanism is yet controversial [10,16,17]. 
According to some studies there is no such 
complication while some agree that it is a 
subclinical complication but no one described the 
characterization of PN [10,18].  PN need to be 
focused as it is important complication of 
cirrhosis of liver that may seriously impair 
patient's routine daily activities and quality of life. 
In our study, liver cirrhosis of more than 5 years 
duration and child Pugh class (A,B,C), were 
studied to determine peripheral neuropathy. The 
mean age of 45.19±8.41 years were evaluated. 
Most of the patients were male 73(61.34%) rather 
than female 42(55.26%) and most had disease for 
more than 10 years. Peripheral neuropathy was 
observed in 115(59.0%) patients with mean age of 
45.27±7.88 years and mean duration of disease 
10.61±2.99 years.  Child pugh class-C was the 
most prevalent (44.1%) and most of the patients 
(63.6%) were smoker. The duration of disease in 
63.07% was 9-11 years and 36.9% was 5-8 years. 
No significant association of peripheral 
neuropathy was observed with smoking, duration 
of disease and child pugh class.  
A study done by Kharbanda PS et al., analyzing 33 
patients with cirrhosis of liver shows mild 
symptoms due to neuropathy in 5 (15%) patients 
while clinical signs were present in 7(21%) 
patients. Sensory impairment was present in 
4(12%), motor weakness in 2(6%), and 5(15.1%) 
with loss deep tendon reflexes [13]. 
 However, results from study done by Kharbanda et 
al.13 and Fawi et al., [15] concluded that PN is very 
common irrespective of the etiology of liver 
disease. Earlier study on nerve biopsies showed, 
xanthomatous deposits in nerves leading to 
mechanical derangement in alcoholics. Although 
alcohol use can independently cause neuropathy, in 
this study, subjects who did not have alcohol as a 
cause for development for cirrhosis of liver also 
had polyneuropathy. 
In a prospective clinical study conducted on 
cirrhosis of liver patients by Knill-Jones et al., PN 
was associated with diabetes mellitus, increased 
levels of immunoglobulin A (IgA) and IgM and not 
with etiology of cirrhosis.19 However we have 
excluded patients with DM from our study. 
Jain J et.al. states that the magnitude of PN was 
higher among smoker compared to those who never 
smoked and odds was 2.27 (95%, CI: 1.10-4.65) 
was significant (P = 0.025). The possible 
explanation for this could be patients who smoke 
also drink alcohol also. However other personal 
habits like tobacco chewing, pan chewing and betel 
nut chewing were not associated with PN [11].  
The cirrhotic patients in a study were divided into 
three classes (A, B, and C) according to the 
severity of disease based on modified CP Score. 
Nerve conduction study values were not 
significantly different in three classes when 
compared. Odds of PN were not significant for 
both CP score B, C (OR = 1.26-1.98; P = 0.242). 
Results of this study were similar to Kharbanda et 
al., [13] Knill-Jones et al., [19] and Fawi et al., 
[15] studies. These observations suggest that the 
possible causes of PN in study subjects of cirrhosis 
of liver might be injury to hepatic parenchyma and 
deranged metabolism leading to accumulation of 
substances which cause nerve damage.     
  
CONCLUSION: 
Very few hepatologist screen patients for 
Peripheral neuropathy due to time-consuming 
neurophysiological tests and association 
controversies. This research concluded that 
peripheral neuropathy is one of the complications 
of liver cirrhosis irrespective of its etiology and is 
more prevalent in male gender, age > 45 years, and 
duration of disease 9-11 years.   
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